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Protein lipoxidation was assessed in the parietal cortex (PC), frontal cortex (FC), and 
cingulate gyrus (CG) in middle-aged and old-aged individuals with no clinical 
manifestations of cognitive impairment, in order to increase understanding of regional 
brain vulnerability to oxidative damage during aging. Twenty-five lipoxidized proteins 
were identified in all the three regions although with regional specificities, by using 
redox proteomics to detect target proteins of neuroketals (NKT) adduction. The number 
of cases with NKT-adducted proteins was higher in old-aged individuals but most 
oxidized proteins were already present in middle-aged individuals. Differences in 
vulnerability to oxidation were dependent on the sub-cellular localization, secondary 
structure, and external exposition of certain amino acids. Lipoxidized proteins included 
those involved in energy metabolism, cytoskeleton, proteostasis, neurotransmission 
and O2/CO2, and heme metabolism. Total NKT and soluble oligomer levels were 
estimated employing slot-blot, and these were compared between age groups. 
Oligomers increased with age in PC and FC; NKT significantly increased with age in 
FC, whereas total NKT and oligomer levels were not modified in CG, thus highlighting 
differences in brain regional vulnerability with age. Oligomers significantly correlated 
with NKT levels in the three cortical regions, suggesting that protein NKT adduction 
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Aging produces changes in the structure and function of biological systems, leading to 
increased vulnerability to disease and death [1]. Senescence results from the 
accruement of declining processes including unbalanced oxidation, accumulation of 
abnormal and damaging molecules, and loss of repair capacities, among other factors 
[2]. In the brain, aging is manifested by reduction in white matter size, selective loss of 
neurons, dendrites and dendritic spines, modifications in neurotransmission, and 
senescence of glial cells [3-6]. Regional vulnerability results from the vulnerability of a 
particular region to damage by distinct noxious stimuli together with its specific capacity 
to react to the harmful stimuli. The combination of external factors such as blood flow 
and internal factors such as specificities of distinct neuronal and glial cell types 
contributes to delineating regional brain profiles of vulnerability during aging [7]. 
Reactive oxygen species (ROS) have been implicated as sources of molecular injury 
when reaching undesirable thresholds [8-9] and have been directly implicated in the 
process of aging [10]. The human brain has high energy metabolism and high oxygen 
consumption demands, relatively low antioxidant defenses when compared with other 
tissues, high rates of transition metals that may act in redox cycles, and high 
concentration of poly-unsaturated fatty acids [11-12]. All these factors make the brain 
highly susceptible to oxidative stress damage during aging. Moreover, some targets of 
oxidative damage are common in aging and neurodegenerative diseases such as 
Alzheimer‟s disease (AD) [13-16].  
Lipid peroxidation is an important source of secondary ROS-mediated injury. Poly-
unsaturated fatty acids present in cell membranes are extremely susceptible to 
peroxidation [17]. Among these, docosahexaenoic acid (DHA; C22:6, ω3) is particularly 
abundant in the brain when compared to other ones such as arachidonic acid; DHA is 
highly concentrated in neuronal membranes and accounts for about one-third of total 
 
 
fatty acids in amino-phospholipids of gray matter [18]. Neuroketals (NKT) are γ-
ketoaldehyde sub-products of the non-enzymatic oxidation of DHA through the 
neuroprostane pathway [19]. NKT adducts lysine residues of proteins with remarkable 
rapidity causing protein lipoxidation and inducing cross-linking and aggregation [20], 
which are common marks of several age-related neurodegenerative disorders [21]. 
Soluble intermediates of protein aggregates named soluble oligomers cause cell injury 
by several mechanisms including mitochondrial damage, increased oxidative stress, 
and reduced protein clearance [22]. Soluble oligomers display a common 
conformation-dependent structure that is unique regardless of sequence and, 
therefore, allows detection with conformation-specific antibodies [23]. This suggests 
that they share a common mechanism of toxicity despite their derivation from different 
proteins [24]. A possible relation between oligomer production and NKT-mediated 
protein damage, and induction of cross-linking and aggregation, is a plausible 
hypothesis triggering cell damage. 
Since the majority of the neurodegenerative diseases with abnormal protein 
aggregates appear in older individuals it is practical to try to gain understanding about 
modifications occurring with age before the time of the appearance of these diseases. 
The reason is not only to gain knowledge about mechanistic aspects but also to identify 
putative rational windows for specific therapeutic intervention. In the context of aging, 
redox proteomics is a very useful tool to identify protein targets of lipoxidative damage 
and to infer possible functional implications [25-26]. 
The present study analyzes lipoxidation in middle-aged and old-aged individuals with 
no clinical manifestations of cognitive impairment in three brain regions: parietal cortex, 
frontal cortex, and cingulate gyrus. Redox proteomics is used to detect target proteins 
modified by NKT adducts. This is followed by the bioinformatic analysis of factors 
contributing to vulnerability of NKT-adducted proteins, considering their localization, 
structure, and functions. Finally, the relation between the presence of soluble 
oligomeric species and NKT-adduction is explored in each region in the different age 








Brain tissue samples were obtained from eighteen cases from the Institute of 
Neuropathology Brain Bank, a branch of the HUB-ICO-IDIBELL Biobank, following the 
guidelines of the Spanish legislation and the approval of the local ethics committee. At 
autopsy, each brain was rapidly removed from the skull. The left hemisphere was fixed 
in 4% buffered formalin for neuropathological study and the right hemisphere cut into 
slices, dissected into selected regions which were separated in individual labeled 
plastic bags, immediately frozen, and stored at -80ºC until use. Three regions were 
studied: parietal cortex Brodmann area 7 (PC), frontal cortex area 8 (FC), and   
cingulated gyrus area 23 (CG). 
A routine neuropathological study was performed in every case [27]. The 
neuropathological examination did not reveal lesions excepting moderate small blood 
vessel disease and status cribosus, and a few neurofibrillary tangles consistent with 
 
 
AD-related pathology stage I of Braak and Braak in older cases. In no cases were 
diffuse and neuritic β-amyloid plaques present. Therefore, hallmarks of AD-related 
pathology were not observed in the PC, FC, and CG in any case. 
The age of subjects ranged from 40 to 79 years (mean 58.9 ± 13.5 years) and five of 
them were females (27.8%). The mean post-mortem delay was 6h15min ± 2h48min 
(minimum 2h, maximum 14h). Markers of protein/nitrosative damage are preserved in 
post-mortem brains within these post-mortem time points [27]. All samples used were 
from individuals who did not have neurological or mental diseases, and had not 
suffered from diabetes, hepatic failure, or renal failure. In all of them there was an 
absence of prolonged hypoxia, sepsis, and agonal state in the context of artificial 
respiratory assistance. The causes of death in these cases were variable including 
carcinoma non-affecting the central nervous system, cardiac infarction, pulmonary 
thrombosis-embolism, and pneumonia. Summary of cases is shown in Table 1. 
 
Two-dimensional (2D) gel electrophoresis 
Samples of the PC, FC, and CG from ten individuals were analyzed with 2D 
electrophoresis (Table 1). These cases were representative of two age groups: five 
were middle-aged cases (mean age 43 ± 2.8 years) and five were old-aged cases 
(mean age 74 ± 5.5 years). The totality of samples was processed on different days. 
From each region, 0.1g of frozen tissue was homogenized in 1mL of ice-cold lysis 
buffer (7M Urea, 2M Thiourea, 40mM Tris pH 7.5 and 4% CHAPS) containing 
phosphatase and protease inhibitors (Roche Molecular Systems). The homogenate 
was centrifuged at 16,000g for 10min at 4°C and the pellet was discarded. Proteins 
from 300µL of the resulting supernatant were precipitated with methanol/chloroform at 
room temperature. Protein pellets were then suspended in 300µL of lysis buffer. 
Protein concentration was determined with the Bradford assay with bovine serum 
albumin (Sigma-Aldrich) as standard. 
For the first dimension electrophoresis, equal amounts of protein (200µg) in lysis buffer 
from each sample were mixed with 0.8% Byo-Lyte 3/10 ampholyte, 5mM TBP, and 
0.0004% bromophenol blue. Next, the sample was applied onto 7 cm pH 3-10 NL 
ReadyStrip™ IPG strips (Bio-Rad) for isoelectric focusing on a Protean® IEF Cell 
system (Bio-Rad) at 20°C and current limit of 50µA per strip. The strips were actively 
re-hydrated at 50V for 14h and focused in sequential steps of 1h at 200V, 1h at 500V, 
1h at 1,000V, 1h at 8,000V, and 10h at 8,000V. After focusing, the strips were stored at 
-20°C until required. 
For the second dimension, the strips were re-equilibrated in equilibration buffer (6M 
urea, 50mM Tris-HCl pH 8.8, 2% SDS, and 20% glycerol) containing 5mM TBP, and 
then alkylated in the same buffer plus 2.5% IAA. Afterwards, the strips were placed on 
the top of 10% SDS-polyacrylamide gels and electrophoresed at 120V at 4°C. Two 
identical gels were run in parallel for each sample. One was silver stained using the 
PlusOne™ Silver Staining Kit as described by the manufacturer (GE Healthcare). The 
other one was processed for western blotting.  
 
NKT-adducted protein identification  
The goat anti-NKT antibody (dilution 1:2,000, Ab5611, Chemicon International) was 
used to detect NKT-adducted proteins. According to the indications of the supplier, the 
antibody, produced using neuroketal-conjugate as immunogen, has been shown to 
react with neuroketal/neuroprostane-modified proteins by ELISA. By western blotting, 
 
 
the antibody reacts with several major and many minor bands in human brain protein 
modifications.    
This antibody has been previously used and validated in several brain regions and 
neurological diseases [28-30].  
NKT-positive spots in the 2D gels were qualitatively compared by visual inspection 
between age groups. The selection of NKT-positive spots was based on the presence 
or increased intensity in old-aged individuals versus absence or reduced intensity in 
middle-aged individuals. 
Selected NKT-adducted protein spots detected by western blot were matched with 
corresponding silver-stained spots in parallel gels. Selected spots were excised from 
2D silver stained gels and subjected to in-gel tryptic digestion using the automatic 
protein digestion system Investigator™ Progest (Genomic Solutions). Briefly, the SDS-
gel spots were cleaned with 25mM ammonium bicarbonate and acetonitrile. Next, the 
sample was reduced (10mM dithiothreitol for 30 min at 56°C) and alkylated (55mM 
iodoacetamide for 30min at 21°C in the dark). Afterwards, each sample was digested 
overnight at 37°C with 80ng of sequencing grade modified trypsin (Promega). Finally, 
the resulting peptide mixture was extracted from the gel matrix with 10% formic acid 
and acetonitrile, and then dried-down. 
The dried-down peptide mixture was analyzed in a nanoAcquity liquid chromatographer 
(Waters) coupled to a LTQ-Orbitrap Velos (Thermo Scientific) mass spectrometer. 
Tryptic peptides were re-suspended in 1% formic acid and each aliquot was injected 
into a nanoAcquity Symmetry C18 trap column (5µm, 180µm x 20mm; Waters). 
Trapped peptides were separated using a C18 nanoAcquity reverse phase capillary 
column (75µm x 100mm, 1.7µm BEH130, Waters). The gradient used for elution of 
peptides was 0 to 40% B in 20 min, followed by a gradient from 40% to 60% in 5 min 
with a 250 nL/min flow rate (mobile phases, A and B, were composed of 0 and 100% 
acetonitrile, respectively, and each contained 0.1% formic acid). Eluted peptides were 
subjected to electrospray ionization in an emitter needle PicoTip™ (New Objective) 
with an applied voltage of 2,000V. Peptide masses (m/z 350-1700) were analyzed in 
data-dependent mode with a full Scan MS in the Orbitrap with a resolution of 60,000 
FWHM at 400m/z. Up to 5 of the most abundant peptides (minimum intensity of 500 
counts) were selected from each MS scan. Then, they were fragmented by collision 
induced dissociation in a linear ion trap using helium as collision gas with 38% 
normalized collision energy. Generated raw data were collected with Thermo Xcalibur 
v.2.1.0.1140 (Thermo Scientific). 
Protein identification 
Raw data were submitted for database searching with the Mascot search engine using 
Thermo Proteome Discover v.1.3.0.339 (Thermo Scientific) against Swiss-Prot 
database. Both target and a decoy database were searched to obtain a false discovery 
rate (FDR) and thus estimate the number of incorrect peptide-spectrum matches 
exceeding a given threshold. The following search parameters were applied: trypsin 
enzyme, 2 missed cleavages, carbamidomethyl of cysteine as fixed modification, 
oxidation of methionine as variable modification, and peptide tolerance of 10 ppm and 
0.6Da (for MS and MS/MS spectra, respectively). 
To improve the sensitivity of the database search, Percolator (semi-supervised learning 
machine) was used to discriminate correct from incorrect peptide spectrum matches. 
Percolator assigns a q-value to each spectrum, which is defined as the minimal FDR at 
which the identification is deemed correct. These q values are estimated using the 
 
 
distribution of scores from decoy database search (Percolator Target FDR, strict: 0.01; 
Validation based on: q-value). The list of resulting proteins was filtered to accomplish 
two restrictions: containing Homo sapiens in the description and having at least 2 high-
confidence peptides (FDR ≤ 0.01). 
 
Western-blotting  
2D gels obtained in a sub-set of samples were used to detect NKT-adducted proteins. 
Total number of cases (n=18) was analyzed by western blotting for total levels of 
selected proteins in mono-dimensional (1D) gels. Equal amounts of total protein for 
each sample were loaded onto 10% SDS-polyacrylamide gels and separated according 
to their molecular weight. Polyacrylamide gels (1D or 2D) were transferred onto 
nitrocellulose membranes using the Trans-Blot® Turbo™ blotting system (Bio-Rad). 
Transferred membranes were blocked with 5% skimmed milk in TBS-T buffer and 
incubated overnight at 4°C with the appropriate primary antibody diluted with 3% BSA 
in TBS-T. Then the membranes were washed in TBS-T and incubated with the 
corresponding secondary antibody labeled with horseradish peroxidase (HRP), and 
washed again in TBS-T. Immunoreactivity was detected with the chemiluminescence 
method (Amersham ECL Western blotting detection reagents, GE Healthcare).  
To validate the LC-MS/MS identification results, selected proteins were tested with the 
corresponding antibodies on the same 2D membranes after stripping. Strip of 
membranes consisted of two sequential washes in stripping buffer (62.5mM Tris-HCl 
pH 6.8, 2% SDS, 100mM β-mercaptoethanol) at 65°C, three washes in TBS-T at room 
temperature, and blockage with 5% skimmed milk in TBS-T buffer. A list of the  
antibodies employed is shown in Supplementary Table 1. 
 
Slot-blot 
The level of soluble oligomeric species was detected with slot blot analysis using the 
anti-oligomers A11 antibody (AHB0052, Invitrogen) according to the manufacturer‟s 
protocol for dot-blotting. A11 antibody detects specific oligomeric structural 
conformations. Previous to this analysis, A11 antibody was tested (by slot-blot with the 
same protocol) against monomeric Aβ40-42; no signal was detected thus confirming the 
specificity of the assay. In order to obtain soluble proteins at non-denaturing 
concentrations of compounds on the original lysis buffer, samples were diluted 1:10 
(v/v) in phosphate buffered saline (137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 2mM 
KH2PO4 pH 7.4) and allowed proteins to re-nature minimizing aggregation. Then, 
samples were centrifuged at 16,000g for 5min at room temperature; the insoluble pellet 
was discarded and protein concentration determined by Bradford assay. 
Equal amounts of total protein of each sample were slot-blotted onto nitrocellulose 
membranes by vacuum using a SHM-48 slot blotter unit (Scie-Plas). Ponceau staining 
(AppliChem GmbH) was used to verify equal protein loads after blotting. The 
membranes were blocked in 10% skimmed milk, incubated overnight with A11 
antibody, washed, incubated with the secondary anti-rabbit HRP conjugated antibody, 
and washed using buffers and dilutions recommended by the supplier. 
Immunoreactivity detection was performed with chemiluminescence as for western-
blots. After oligomer detection, the membranes were stripped and tested against NKT 
to explore possible quantitative relation in the amount of NKT and oligomeric species in 





Densitometry of monodimensional gel protein bands and slots was used to determine 
expression levels. The quantification analysis was performed with TotalLab software 
(Nonlinear Dynamics). β-tubulin in monodimensional gels and total protein (from 
Ponceau staining) in slots were used as internal controls of protein loading prior to 
statistical analysis. 
 
Bioinformatics-based protein characterization 
Proteins under study were identified by their UnitProt database accession numbers 
(http://www.uniprot.org/); particular cellular locations and functions are reported in 
accord with this database. For analysis of the structural features PredictProtein web-
based software (https://www.predictprotein.org/) was employed. Functional protein-
protein interaction network analysis was performed using the web-based STRING 
software (http://www.string-db.org/) [31]. Gene Ontology (GO) and pathway analysis 
was performed using Cytoscape software with the ClueGO and CluePedia plugins 
including information from KEEG, REACTOME, and STRING databases [32, 33]. 
 
Statistical analyses 
Descriptive data were expressed as mean ± standard deviation or as percentages 
when needed. Kruskal-Wallis test with Lilliefors correction was used to probe the 
normality assumption for continuous variables. Student‟s t test and Mann-Whitney U 
test, as appropriate, were used to evaluate differences between age groups. Pearson 
correlations were employed to assess possible relations among variables. In addition, 
NKT and soluble oligomer levels were subjected to factor analysis using Principal 
Components Analysis (PCA). For all the tests, p-values less than 0.05 were considered 





2D gel electrophoresis and NKT adducted-protein identification 
PC, FC, and CG samples of the ten cases covering the two groups of age distribution 
(middle-aged, old-aged) were analyzed with 2D electrophoresis and anti-NKT western 
blotting. NKT-positive spots were qualitatively compared by visual inspection between 
age groups. Thirty-nine NKT-positive spots were selected as being of interest based on 
increased intensity or presence in old-aged individuals (Figure 1). The corresponding 
spots in the silver-stained gels processed in parallel were excised, in-gel digested, and 
analyzed with LC-MS/MS for protein identification. The full list of spots and the 
corresponding LC-MS/MS resulting identifiers is shown in Table 2. 
 
Validation of identified proteins 
In order to corroborate that protein gel spots were accurately identified by LC-MS/MS, 
thirteen top candidate proteins (ATP5A1, BASP1, CKB, CRYAB, ENO1, GAPDH, 
GFAP, HBA1, HSPD1, NEFL, PARK7, UCHL1 and YWHAG) were analyzed. 2D anti-
NKT blotted membranes were stripped and blotted against specific antibodies 
corresponding to proteins of interest (Supplementary Figure 1). The resulting spots 
were matched with the original ones over the same 2D membrane, and protein 
 
 
identities were corroborated. However, UCHL1 matched a group of NKT-positive spots 
but displaced to a more basic isoelectric point. 
 
NKT adducted proteins with respect to age in each region 
A final list of twenty-five protein targets of lipoxidation by NKT adduction is shown in 
Table 3 which includes their locations and functions. The number of cases per age 
group and region in which proteins were oxidized is presented in Figure 2. 
In the PC (Figure 2A), 8 proteins (32%) showed the same levels of lipoxidation in both 
age groups (ATP5A1, DLD, GFAP, NEFL, NEFM, HSPD1, BASP1, and SYN1) while 
17 (68%) manifested increased lipoxidation with age (CKB, GAPDH, PGAM1, ENO1, 
PKM2, ACO2, TPPP, PARK7, CRYAB, GOT1, DPYSL2, YWHAG, HBA1, CA1, 
BLVRB, PEBP1, and UCHL1). Four of them (PKM2, ACO2, CRYAB, and HBA1) were 
oxidized only in old-aged cases. 
In the FC (Figure 2B), 6 proteins (24%) showed no differences in the presence of NKT 
adduction between middle-aged and old-aged individuals (CKB, GAPDH, GFAP, 
NEFL, NEFM, and HSPD1) whereas 19 proteins (76%) presented increase in the NKT 
adducted forms in old-aged individuals (PGAM1, ENO1, PKM2, ACO2, ATP5A1, DLD, 
TPPP, PARK7, CRYAB, GOT1, DPYSL2, BASP1, YWHAG, HBA1, CA1, BLVRB, 
PEBP1, SYN1, and UCHL1). One protein, HBA1, was lipoxidized only in old-aged 
individuals. 
In the CG (Figure 2C), 7 proteins (28%) showed no differences between groups 
(PKM2, GFAP, NEFL, NEFM, HSPD1, DPYSL2, and YWHAG) whereas increased 
lipoxidation occurred in the 18 remaining proteins (72%) in older cases (CKB, GAPDH, 
PGAM1, ENO1, ACO2, ATP5A1, DLD, TPPP, PARK7, CRYAB, GOT1, BASP1, HBA1, 
CA1, BLVRB, PEBP1, SYN1, and UCHL1). 
The most frequently lipoxidized proteins, accounting for at least 70% of cases, were 
GFAP (100%), HSPD1 (100%), CKB (93.33%), GAPDH (93.33%), NEFL (93.33%), 
NEFM (80%), DPYSL2 (80%), DLD (73.33%), PEBP1 (70%), and SYN1 (70%). 
Considering the cumulative presence of lipoxidized proteins by age group (Figure 2D), 
lipoxidation of specific proteins in all the regions increased in old-aged individuals. In 
the PC, values of cumulative count varied from 48 in middle-aged to 67 in old-aged 
cases. In FC, values varied from 79 in middle-aged to 107 in old-aged; whereas in the 
CG, there were 76 in middle-aged and 104 in old-aged individuals. 
 
Quantification of selected lipoxidized protein levels 
To determine whether increased lipoxidation of certain proteins might not be merely the 
result of the increased expression levels of that particular protein, selected protein 
levels were quantified. Proteins with no differences in any region (GFAP, NEFL, NEFM 
and HSPD1) were excluded. Proteins for which no commercial antibodies wee 
available (PKM2, DPYSL2, DLD, PEBP1, SYN1, GOT1, PGAM1, ACO2, TPPP, CA1 and 
BLVRB) were not analyzed. Finally, six lipoxidized proteins with increased cumulative 
levels of lipoxidation in old aged cases at least in two regions were assessed using 1D 
SDS-PAGE electrophoresis and western blotting with specific available antibodies: 
ATP5A1, CKB, ENO1, GAPDH, YWHAG and UCHL1. Quantification of the bands was 
carried out by densitometry (Supplementary Figure 2). Protein levels were compared 
between age in each region after checking normality of variables (non-normal data: 
ATP5A1 in PC; ENO1 and HBA1 in FC; and UCHL1 in CG). Statistical results of these 
 
 
comparisons are summarized in Supplementary Table 2, and graphically represented 
in Supplementary Figure 3. There were no significant differences in the total expression 
levels of assessed proteins in any region when comparing middle-aged and old-aged 
groups, excepting significant decreased levels of YWHAG (p < 0.02) in the FC in the 
old-aged group, thus indicating that increased lipoxidation levels of defined proteins 
were not the result of increased expression of the corresponding total protein. 
 
Characterization of lipoxidized proteins 
To learn about the commonalities of proteins vulnerable to lipoxidation, their structures 
were analyzed using PredictProtein web-based software. The structural characteristics 
are represented in Figure 3.  
Excluding BASP1, in which 100% is loop or disorganized, α-helix motive represents 
between 5.14 and 83.10%, β-strand represents between 1.2 and 31.43% (absent in 
NEFL and HBA1), and loops represent between 16.9 and 75.46% (Figure 3A). Proteins 
with secondary structures forming α-helix plus loops represent between 68.5% and 
98.8%. Interestingly, exposure to the medium varied between 42.6% and 100%, and it 
was superior to 50% in 16 proteins (Figure 3B). 
Regarding amino acid composition, the most common amino acids represented are 
alanine (mean frequency in the group: 9.71%), leucine (mean frequency in the group: 
8.74%), and glycine (mean frequency in the group: 8.02%) as reported for the total pull 
of proteins present in Swiss-Prot database. However, the most frequent amino acids 
encountered in the exposed regions of lipoxidized proteins are lysine (mean frequency: 
12.16%), glutamic acid (mean frequency: 11.44%), and aspartic acid (mean frequency: 
8.53%) (Figure 3C). 
With respect to the cellular location, analysis of GO term “cellular component” 
annotation revealed that the best represented sub-cellular localizations of lipoxidized 
proteins were cytoplasm, cytoskeleton, mitochondrion, and exosome. For the GO term 
“molecular function” lipoxidized proteins over-represented terms are binding, catalytic 
activity, and structural molecule. 
Interactions of these proteins were explored using the STRING web-based tool. The 
network of interactions used for the analysis with a high confidence level of combined 
score computed and no more than 10 external partners is shown in Figure 4. 
Interestingly, the central node of the resulting network is occupied by ubiquitin. 
The over-represented functional pathways in which lipoxidized proteins are involved 
were explored using Cytoscape software. The results from this analysis are presented 
in Figure 5 showing a high representation of GO term for processes related with energy 
metabolism (including glycolysis and gluconeogenesis, citric acid cycle, mitochondrial 
respiration, and rapid energy production), intermediate filament based process, axon 
cargo transport, cytoskeleton-dependent intracellular transport, protein stabilization, 
mitochondrial protein import, and carbon-oxygen lyase activity. Roughly 32% of 
lipoxidized proteins are involved in energy metabolism (CKB, GAPDH, PGAM1, ENO1, 
PKM2, ACO2, ATP5A1, and DLD), 16% in cytoskeleton-related functions (GFAP, 
NEFL, NEFM, and TPPP), 16% in proteostasis (HSPD1, PARK7, CRYAB, and 
UCHL1), 24% in neurotransmission directly or indirectly (PEBP1, SYN1, GOT1, 
DPYSL2, BASP1, and YWHAG), and the remaining 8% and 4% in O2/CO2 (HBA1 and 
CA1) and heme-group metabolism (BLVRB), respectively. 
 
Soluble oligomers and NKT levels 
 
 
The levels of soluble oligomers as revealed with the A11 antibody (Figure 6A) and NKT 
(Figure 6B) were detected with slot-blot densitometric analysis comparing middle-aged 
versus old-aged cases in every region using Student‟s t-test. Soluble oligomer levels 
were significantly increased in the older group with respect to middle-aged cases in the 
PC (t = -2.83, p < 0.01) and FC (t = -3.98, p < 0.001), whereas, no significant 
differences were found between age groups in the CG. With respect to NKT, only 
significantly increased levels (t = -3.32, p < 0.005) were found in the old-aged group 
when compared with middle-aged cases in the FC. 
The same pattern was found when results were analyzed for significant continuous 
relations with age (Pearson‟s correlation). Positive significant correlations with age for 
oligomers in PC (r = 0.52, p < 0.045), for oligomers (r = 0.65, p < 0.008), and for NKT (r 
= 0.57, p < 0.025) in FC (Figure 6C). No correlation was found with age in the CG. 
Significant positive correlations were seen between oligomers and NKT levels present 
in each one of the explored regions (PC: r = 0.70, p < 0.004; FC: r = 0.89, p < 0.000; 
CG: r = 0.86, p < 0.000), which are represented in Figure 7A. 
To reduce dimensionality while preserving the maximum amount of information to infer 
significant associations between variables, Principal Components Analysis was used 
including oligomers and NKT levels for each region as active variables and age as 
supplementary variable (Figure 7B). Two principal components explained 83.18% of 
the variance in the data, the first component (Factor1: 52.49% of the variance) with a 
high information contribution from oligomer and NKT levels in PC and FC, and the 
second component (Factor 2: 30.69% of the variance) with information from oligomer 
and NKT levels in CG. Both factors were negatively correlated to age, but factor 1 
showed a closer relation than factor 2. The projection of variables in the factor-plane 
graph summarizes this information, showing the closer positive relation of soluble 
oligomers and NKT levels in PC and FC among them and with age, and the more 




Protein lipoxidation in human cerebral cortex occurs at middle age and increases with 
physiological senescence 
Cases analyzed were considered normal individuals with no neurological or mental 
diseases and with no neuropathological alterations excepting stage I of Braak and 
Braak and moderate status cribosus in some older cases. About 80% of individuals 
aged 65 years have neurofibrillary tangles in the entorhinal and transentorhinal cortices 
[34]. Factors other than age that might have interfered with the analysis of oxidized 
proteins, such as metabolic diseases and hypoxia were ruled out. Causes of death 
were similar in the two groups of cases. Post-mortem delay was within the range of 
feasibility [27]. Finally, the NKT antibody has been used and validated in previous 
studies [28-30]. 
Twenty-five NKT-adducted proteins were identified in the cerebral cortex of normal 
middle-aged and old-aged individuals. Four proteins, GFAP, NEFL, NEFM, and 
HSPD1, showed the same cumulative presence of NKT-adducted forms in the three 
regions and in both age groups. Some proteins having the same cumulative levels of 
NKT adducted forms in both age groups were identified in distinct regions: ATP5A1, 
DLD, BASP1, and SYN1 in PC; GAPDH and CKB in the FC; and PKM2, DPYSL2, and 
 
 
YWHAG in the CG. However, adducted forms of all these proteins in a particular region 
increased in the other two regions in old-aged individuals. 
The degree of lipoxidation of the vast majority of remaining proteins identified by the 
accumulation of NKT adducts was higher in old-aged individuals when compared to 
middle-aged cases in spite of regional variations. These proteins are PGAM1, ENO1, 
ACO2, TPPP, PARK7, CRYAB, GOT1, HBA1, CA, BLVRB, PEBP1, and UCHL1. 
However, certain proteins were lipoxidized only in old-aged individuals in certain 
regions such as PKM2, HBA1, and CA in the PC, and HBA1 in the FC.  
Together, these observations show, on the one hand, that the cerebral cortex in 
individuals aged between 40 and 48 years contains lipoxidized proteins the levels of 
which vary from one region to another, and, on the other hand, that cumulative 
presence of NKT adducted forms increases in individuals aged between 70 and 79 
years. 
Importantly, increased lipoxidation is not related to increased levels of the 
corresponding protein but rather to increased vulnerability to lipoxidation with age as 
revealed by the higher values of oxidation compared with preserved total levels of the 
same protein. 
 
Selective protein lipoxidation in human cerebral cortex 
Susceptibility to lipoxidation is not uniform in all proteins [14, 35]. Assuming that ROS 
act stochastically, several factors can influence this specificity beyond abundance 
including structure, location, and functional characteristics. Localization of proteins, a 
particular cell type or subcellular compartment, may make them more vulnerable as a 
result of their environmental conditions [36]. An example of cell type-related 
vulnerability is GFAP localized in astrocytes which are the main brain producers of 
DHA [37] and its peroxidation derivatives. Regarding subcellular localization, HSPD1 
and DLD are located in the mitochondria, the principal source of ROS [38]. NEFL and 
NEFM are proteins of the cytoskeleton, as well as DPYSL2 which is also located in the 
growth cones; PEBP1 is involved in neurotransmission and SYN1 is present in synaptic 
vesicles. It is worth stressing that axons and synaptic terminals have high energy 
demands achieved by continuous mitochondrial activity and recruitment, and rapid 
energy transduction mediated by CKB. In addition, axons are radial structures with a 
small diameter in comparison with the cell body which increases the probability of 
stochastic interactions between ROS and membrane lipids, thus propitiating lipid 
peroxidation. 
The present findings also show that certain structural traits, mainly the presence of 
alpha helices and loops, render proteins susceptible to oxidative damage. Excepting 
cytoskeletal proteins, the rest of the proteins identified as targets of lipoxidation 
(excluding BASP1 which is completely disordered) are globular and form soluble 
coiled-shaped molecules with hydrophobic groups at the core and exposed hydrophilic 
groups. Moreover, proteins with the revealed amino acids lysine, glutamic acid, and 
aspartic acid are also particularly vulnerable; the average level of exposure is greater 
than 50% in sixteen proteins. 
 
Functional clustering of oxidatively-damaged proteins 
Principal systems affected by protein lipoxidation, considering the number of identified 
damaged proteins, are energy metabolism, cytoskeleton, proteostasis, 
neurotransmission, and O2/CO2 and heme metabolism. 
 
 
There is strong evidence that energy metabolism is particularly affected during aging 
and neurodegeneration [8, 11, 17]. The present observations give some clues about 
the molecular substrates of energy failure with aging after the identification of key 
proteins as targets of lipoxidative damage, including proteins of the glycolysis GAPDH, 
PGAM1, ENO1, and PKM2; proteins of the citric acid cycle ACO2 and DLD; and 
ATP5A1 subunit of the respiratory mitochondrial complex V. All of them are 
components of coupled processes necessary to fulfill ATP requirements of cells. 
Neuronal activity is highly dependent on these processes since, under normal 
conditions, glucose is the exclusive energy substrate for the brain [39]. In addition, CKB 
is in charge of rapid ATP production from phosphocreatine reservoirs in response to 
acute increased energy demands in neurons, but CKB is also a key player in the 
„phosphocreatine circuit‟ for cellular energy homeostasis [40]. Thus CKB provides 
neurons with a reservoir and also an alternative source of ATP from glycolysis, citric 
acid cycle, and respiration. 
Cytoskeletal GFAP, NEFL, and NEFM are filamentous proteins composed of long 
parallel chains, linked by disulphide cross bridges, making the proteins very stable and 
prone to long half-lives. The present results are in line with previous observations 
showing that neurofilaments are major targets of 4-hydroxinonenal adduction (another 
marker of lipid peroxidation that covalently links lysine) in mice nervous system [41, 
42]. They also support the concept that oxidation of certain cytoskeletal proteins is 
under a tightly regulated mechanism of redox control during life-span [41]. Whether 
these changes do occur in the same direction in other brain regions is not known; nor is 
the functional implication of the high constant levels of oxidation of GFAP, NEFL, and 
NEFM in the three regions examined of the cerebral cortex understood. Moreover, a 
certain degree of lipoxidation in selected cytoskeletal proteins turns out perhaps to be 
useful for the normal functioning of the cytoskeleton. Whether possible disturbances of 
tubulin polymerization result from increased NKT adducts with aging in TPPP remains 
speculative. 
Oxidation of chaperones involves mitochondrial (HSPD1) and cytosolic (CRYAB) 
molecules. HSPD1 modulates protein import and folding into the mitochondria [43]; 
CRYAB exhibits chaperone-like activity, and is able to prevent protein aggregation 
during stress situations while also increasing the resistance of cells to oxidative injuries 
[44]. PARK7 is a redox-dependent chaperone that reduces intracellular ROS through 
oxidation of itself [45], maintains mitochondrial homeostasis [46], and regulates gene 
transcription [47]. 
Regarding oxidized proteins linked to neurotransmission, PEBP1 modulates choline 
acetyltransferase during acetylcholine synthesis [48]. Phosphoprotein SYN1 coats 
synaptic vesicles, modulating synaptic vesicle release, synaptic transmission, and 
plasticity [49]. GOT1 participates in the synthesis and regulation of the levels of 
glutamate [50], the neurotransmitter responsible for around 90% of the excitatory 
synapsis on the brain. BASP1 is found in nerve terminals, enriched in synaptic vesicles 
and in the lipid raft fraction of synaptic plasma membranes [51]; BASP1 regulates the 
transport of glutamic acid decarboxylases to the presynaptic terminals and their 
anchoring to the synaptic vesicles [52. DPYSL2 has relevant functions in axon 
guidance and neurite outgrowth, as well as in synaptic vesicle and N-methyl-
Daspartate glutamate receptor trafficking [53]. YWHAG is a member of the 14-3-3 
group of proteins which display a plethora of functions, among them the ability to 
activate tryptophan and tyrosine hydroxylases, the rate-limiting enzymes in the 
 
 
synthesis of serotonin and catecholamines, respectively [54]. These modifications 
together with those linked to the high energy demands make synapses especially 
vulnerable to oxidative stress damage. 
Three proteins related to heme metabolism and O2 and CO2 regulation, BLVRB, CA 
and HB1A, are also oxidatively damaged. CA participates in the conversion of CO2 into 
bicarbonate and participates in the transport of CO2 out of the tissues. BLVDR 
regulates the final step in heme metabolism, but it also regulates glucose metabolism 
and has neuroprotective effects [55]. HBA1 is a component of haemoglobin whose role 
in the nervous system is still poorly understood. Haemoglobin has been found in 
neurons where it probably plays a role in O2 transport or as a regulator of cytosolic 
neuronal O2 [56]. Interestingly, haemoglobin levels are reduced in neurons in AD [57]. 
Oxidative damage of, at least, those three proteins tags cell O2 and CO2 regulation as a 
target of putative cellular respiratory dysfunction in the elderly. 
Finally, molecular interactions of lipoxidized proteins in the human cerebral cortex were 
explored to identify systems that may be indirectly impaired as a result of primary 
protein lipoxidation and presumable loss of function. Ubiquitin C has been identified as 
the central node of the network of interactions. Ubiquitin conjugation to proteins plays a 
cardinal role in the ubiquitin-proteasome system and protein turnover which has been 
identified as being affected in neurodegenerative diseases associated with aging [58]. 
Since ubiquitin conjugation to target proteins occurs through the ε-amino group of 
lysine, NKT adduction of this group can restrain protein-ubiquitin interactions and then 
hamper the degradation of altered proteins. In addition, 50% of the ubiquitin binding 
sites are not involved in protein degradation by the ubiquitin-proteasome system [59], 
suggesting that ubiquitin serves other molecular pathways. If true, several pathways 
can be deregulated as a result of altered ubiquitin conjugation with oxidized proteins. 
 
NKT adduction and soluble oligomers 
Aberrant protein structures are able to generate soluble oligomers; such molecular 
species are increasingly recognized for their high cytotoxic potential [22, 60]. Soluble 
oligomers have been detected by using the structure-specific amino acid sequence 
independent antibody A11 [23]. Therefore, although initially generated to recognize β-
amyloid soluble oligomers, undefined oligomeric species can be detected as well. 
NKT adduction of proteins generates aberrant structures like crosslinking and 
aggregation [19]. For this reason, global levels of protein NKT adduction and the 
presence of oligomers have been analyzed in every sample. A positive significant 
relation is found between protein NKT and soluble oligomer levels in the three cortical 
regions assessed, suggesting that modifications of proteins resulting from NKT 
adduction parallel soluble oligomer formation. Levels of oligomers increase with age in 
the PC and FC, and NKT levels significantly increase with age just in FC, whereas at 
CG total NKT and oligomer levels showed no differences between age groups.  
The present findings also complement previous observations showing increased levels 
of soluble oligomers in the entorhinal and frontal cortices when comparing middle-aged 
individuals lacking AD related pathology with older cases with AD-related pathology 
stages I-II. Thus, increased levels of soluble oligomers are indeed a characteristic 
feature of the aging human brain coincidental with first stages of AD-related pathology 
[61]. Importantly, increased levels of oligomeric species parallel expression levels of 
brain cytokines and mediators of the immune response in old age [61]. Whether these 
 
 
coincidences have a cause-effect relationship needs further study using appropriate in 
vitro and in vivo models. 
 
Implications on regional brain functions   
The present observations may have implications in brain function. FC area 8, a part of 
the dorsolateral prefrontal cortex, participates in executive functions in connection with 
other brain regions including PC [62, 63]. PC area 7 is also linked to several high-level 
processing tasks [64]. Interestingly, the molecular relationship found between PC and 
FC complements findings from tractography showing an anterior-posterior gradient in 
age-related white matter degradation of specific long-range white matter tracts 
connecting FC and PC [64]. In the same study, reduced frontal tract integrity correlated 
with reduced executive and working memory functions. This accounts, at least in part, 
for cognitive performance decline in older adults. Interconnection of FC and PC is also 
important in the elderly as in healthy old-aged subjects PC is compensatorily recruited 
to perform frontal cortex cognitive tasks [65]. Analysis of the principal components in 
the present study reveals similar patterns of protein oxidation and oligomer burden in 
PC and FC, and relative independence of the CG during aging.  
CG area 23 has a central role in supporting internally-directed cognition. It is a key 
component of the default mode network which is involved in self-referential functions 
and is highly correlated with activity at rest [66]. The posterior CG exhibits a transitional 
pattern of connectivity coordinating distinct networks for efficient cognitive function [67]. 
In line, posterior CG presents a striking high rate of metabolism: cerebral blood flow 
and metabolic rate are around 40% greater than average within the region in human 
brain [68]. Reduced metabolism in this region is accompanied by reduced CG 




Together, the present findings provide information about increased protein damage by 
lipoxidation with aging, which may compromise vital cell functions such as energy 
metabolism, cytoskeleton, proteostasis, neurotransmission, O2/CO2, and heme 
homeostasis. Post-translationally modified proteins resulting from oxidative damage, in 
addition to certain oligomeric species, truncated proteins, lipids, and metabolites, can 
be considered as putative collaborative factors contributing to neuronal senescence. 
Protein vulnerability to oxidation is related to the particular sub-cellular localization of 
certain proteins, the secondary structure of the protein, and the external exposure of 
certain amino acids which are more vulnerable to lipoxidation. Increased oxidative 
damage of key proteins in the FC, PC and CG may impact on normal brain function 
particularly in cognition, integrative connectivity and coordination of activation-rest 
responses in brain. Importantly, since lipoxidative damage to proteins is already 
identified in normal middle-aged individuals and it increases physiologically in the 
elderly, it seems reasonable to act upon the appropriate ROS-producer targets at the 
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Neuropathology 2D 1D Slot-Blot 
1 40 Middle-aged Female CA 8h 45min NL X X - 
2 40 Middle-aged Male PNEU 5h 10min NL X X X 
3 44 Middle-aged Male THR_EMB 6h 40min NL X X - 
4 45 Middle-aged Male C-INF 4h 5min CRIB X X X 
5 46 Middle-aged Female MYO 7h 15min CRIB X X X 
6 48 Middle-aged Female CA 4h 5min NL - X X 
7 52 Middle-aged Male PNEU 9h 30min NL - X X 
8 52 Middle-aged Male C-INF 4h 40min NL - X X 
9 57 Middle-aged Male PNEU 5h 20min NL - X X 
10 61 Old-aged Male CA 4h 30min AD I - X X 
11 65 Old-aged Male CA 3h 15min AD I X X X 
12 66 Old-aged Male THR-EMB 6h 25min NL - X X 
13 67 Old-aged Male CA 14h 40min AD I - X X 
14 70 Old-aged Male CA 2h AD I - X X 
15 75 Old-aged Female C-INF 6h 10min AD I X X X 
16 76 Old-aged Male PNEU 6h 30min AD I X X X 
17 77 Old-aged Male C-INF 6h 55min AD I X X X 
18 79 Old-aged Female INT-INF 6h 25min AD I X X - 
NL: no lesions; CRIB: status cribosus; AD I: Alzheimer disease-related pathology with Braak and Braak stage I of neurofibrillary 
degeneration; 2D: Two-dimensional electrophoresis; 1D: Mono-dimensional electrophoresis; CA: carcinoma; PNEU: pneumonia; C-INF: 






















1 Dihydropyrimidinase-related protein 2 (DPYSL2) Q16555 724.28 48.43 62.25 6.38 
2 Dihydropyrimidinase-related protein 2 (DPYSL2) Q16555 1085.17 62.76 62.25 6.38 
3 60 kDa heat shock protein, mitochondrial (HSPD1) P10809 4087.37 83.60 61.02 5.87 
4 60 kDa heat shock protein, mitochondrial (HSPD1) P10809 2275.19 77.49 61.02 5.87 
5 60 kDa heat shock protein, mitochondrial (HSPD1) P10809 4285.96 89.35 61.02 5.87 
6 60 kDa heat shock protein, mitochondrial (HSPD1) P10809 2412.60 72.25 61.02 5.87 
7 Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) 
P04406 1937.82 88.06 36.03 8.46 
8 Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) 
P04406 1711.18 70.45 36.03 8.46 
9 Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) 
P04406 2334.34 79.10 36.03 8.46 
10 Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) 
P04406 842.06 43.28 36.03 8.46 
11 Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) P09936 1082.92 78.03 24.81 5.48 
12 Protein DJ-1 (PARK7) Q99497 625.43 89.42 19.88 6.79 
13 Protein DJ-1 (PARK7) Q99497 1262.00 89.42 19.88 6.79 
14 Protein DJ-1 (PARK7) Q99497 1065.72 85.71 19.88 6.79 
15 Protein DJ-1 (PARK7) Q99497 808.75 89.42 19.88 6.79 
16 Alpha-crystallin B chain (CRYAB) P02511 2069.68 97.14 20.15 7.53 
17 Phosphatidylethanolamine-binding protein 1 (PEBP1) P30086 2255.23 81.28 21.04 7.53 
18 Neurofilament medium polypeptide (NEFM) P07197 479.13 12.77 102.41 4.91 
19 Neurofilament light polypeptide (NEFL) P07196 902.93 41.25 61.47 4.65 
20 Pyruvate kinase isozymes M1/M2 (PKM2) P14618 860.77 42.94 57.90 7.84 
21 Dihydrolipoyl dehydrogenase, mitochondrial (DLD) P09622 337.68 25.34 54.14 7.85 
22 Brain acid soluble protein 1 (BASP1) P80723 800.65 81.50 22.68 4.63 
23 Glial fibrillary acidic protein (GFAP) P14136 1830.71 64.35 49.85 5.52 
24 ATP synthase subunit alpha, mitochondrial (ATP5A1) P25705 1447.00 46.65 59.71 9.13 
25 Alpha-enolase (ENO1) P06733 709.67 33.87 47.14 7.39 
26 Alpha-enolase (ENO1) P06733 728.28 41.71 47.14 7.39 
27 Creatine kinase B-type (CKB) P12277 724.17 56.96 42.62 5.59 
28 Aspartate aminotransferase, cytoplasmic (GOT1) P17174 1116.53 68.28 46.22 7.01 
29 14-3-3 protein gamma (YWHAG) P61981 1494.57 80.97 28.28 4.89 
30 Hemoglobin subunit alpha (HBA1) P69905 1400.82 85.21 15.25 8.68 
31 Synapsin-1 (SYN1) P17600 315.53 32.06 74.07 9.83 
32 Aconitate hydratase, mitochondrial (ACO2) Q99798 606.55 34.36 85.37 7.61 
33 Dihydrolipoyl dehydrogenase, mitochondrial (DLD) P09622 504.52 28.29 54.14 7.85 
34 Alpha-enolase (ENO1) P06733 2341.02 55.53 47.14 7.39 
35 Carbonic anhydrase 1 (CA1) P00915 481.65 52.49 28.85 7.12 
36 Phosphoglyceratemutase 1 (PGAM1) P18669 261.15 65.75 28.79 7.18 
37 Tubulin polymerization-promoting protein (TPPP) O94811 528.08 36.07 23.68 9.44 
38 NADPH-Flavin reductase (BLVRB) P30043 323.79 42.23 22.11 7.65 






Table 3: Lipoxidized proteins: localization and functions 
Protein Main localization Functions 
  Energy metabolism  
Creatine kinase B-type (CKB) Cytosol, EVE Energy transduction 
Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH)  
Cytosol, cytoskeleton, 
nucleus, EVE 








Glycolysis (step 9); growth control; hypoxia tolerance; immune 
responses 
Pyruvate kinase isozymes 
M1/M2 (PKM2) 
Cytosol, nucleus, EVE 
Glycolysis (last step); linked to caspase-independent 
programmed cell death 
Aconitate hydratase (ACO2) Mitochondrion, nucleus 
Catalyzes the isomerization of citrate to isocitrate within the 
tricarboxylic acid cycle 
ATP synthase subunit alpha 
(ATP5A1) 
Mitochondrion, EVE 
Component of the ATP synthase complex which produces 




Component of the pyruvate, α-ketoglutarate and branched-
chain amino acid dehydrogenase complexes, and of the 
glycine cleavage system  
  Cytoskeleton 
Glial fibrillary acidic protein 
(GFAP) 
Glial cytoskeleton - 
intermediate filament 
Structural constituent of cytoskeleton; cell-specific marker that 
distinguishes astrocytes  










Neuronal cytoskeleton; maintenance of neuronal caliber; axon 
cargo transport 
Tubulin polymerization-
promoting protein (TPPP) 
Cytoskeleton, nucleus, 
EVE 
Integrity of microtubule network; mitotic spindle assembly and 
nuclear envelope breakdown 
  Proteostasis 
60 kDa heat shock protein, 
mitochondrial (HSPD1)  
Mitochondrion, cytosol, 
EVE 
Mitochondrial protein import and macromolecular assembly; 
folding of proteins; apoptotic process 
Protein DJ-1 (PARK7) 
Cytosol, nucleus, 
mitochondrion, EVE 
Protects against oxidative stress and cell death; chaperone 
activity; pleotropic regulatory activities 
Alpha-crystallin B chain 
(CRYAB) 
Cytosol, nucleus, EVE 
Chaperone-like activity; prevents aggregation of proteins under 
stress conditions 
Ubiquitin carboxyl-terminal 
hydrolase L1 (UCHL1) 
Cytosol, membrane, ER, 
EVE 
Processing of ubiquitin precursors and ubiquitinated proteins 
  Neurotransmission 
Aspartate aminotransferase 
(GOT1) 
Cytosol, nucleus, EVE 
Biosynthesis of L-glutamate; regulator of glutamate levels; 
scavenger of glutamate in neuroprotection 
Dihydropyrimidinase-related 
protein 2 (DPYSL2) 
Cytosol, cytoskeleton, 
membrane, EVE 
Neuronal development and polarity including axon growth and 
guidance, growth cone collapse and cell migration; synaptic 
vesicle trafficking 
Phosphatidylethanolamine-
binding protein 1 (PEBP1) 
Cytosol nucleus, EVE 
Binds ATP, opioids and phosphatidylethanolamine; inhibitor of 
serine proteases and RAF1 kinase activity 
Synapsin-1 (SYN1) 
Golgi apparatus, synaptic 
vesicle 
Coats synaptic vesicles and regulates neurotransmitter 
release; pre-synaptic nitric oxid functions  




Protein and DNA binding; transcription regulatory activity; 
development regulation 
14-3-3 protein gamma 
(YWHAG) 
Cytosol, EVE 
Regulation of a large spectrum of general and specialized 
signaling pathways 
  O2/CO2/heme metabolism 
Hemoglobin subunit alpha 
(HBA1) 
Cytosol, EVE Oxygen transport 





Oxidoreductase: catalyzes NADPH-dependent reduction of a 
variety of flavins; heme catabolism;  
Note: Localization and functions based on the reported in the UniProt database (http://www.uniprot.org/). ER, endoplasmic 
reticulum; EVE, extracellular vesicular exosome. Proteins are separated into the groups: energy metabolism, cytoskeleton, 





Figure 1: Bi-dimensional (2D) gel electrophoresis and western blotting to neuroketal (NKT) 
of the parietal cortex (A), frontal cortex (B) and cingulate gyrus of two representative 
samples of middle-aged (40 years, left column) and old-aged (76 years, right column) 
individuals (corresponding to cases 1 and 16 in Table 1). Thirty nine spots (labeled in white 
numbers) were selected considering NKT adduction differences in all the cases analyzed 
for further identification by mass spectrometry. 
 
Figure 2: Number of cases by age group with presence of neuroketal adducted forms of 
the twenty five selected proteins identified by redox proteomics in the parietal cortex (A), 
frontal cortex (B), cingulate gyrus (C) and cumulative counts of the three regions (D). 
Proteins are discriminated into clusters corresponding to energy metabolism, cytoskeleton, 
proteostasis, neurotransmission, and O2/CO2/heme metabolism. Number of cases with 
protein neuroketal adducts are higher in old-aged when compared with middle-aged 
individuals, but most oxidized proteins are already present in middle-aged individuals. Note 
that the cytoskeletal proteins GFAP, NEFL and NEFM, and the chaperone HSPD1 show 
the same level of oxidative modifications in middle-aged and old-aged individuals. 
 
Figure 3: Structural characterization of the group of neuroketal-adducted proteins as 
revealed with the PredictProtein software analysis. Predominant structures of oxidized 
proteins are helix and loops (A). Most proteins have structures exposed to solvents (B). The 
most frequent amino acids exposed are lysine, glutamic acid and aspartic acid (C). 
 
Figure 4: Protein-protein interactions networks derived from the STRING software analysis 
of the identified neuroketal-adducted proteins. Several robust interactions are encountered 
in the diagram; interestingly, ubiquitin is a center interacting molecule for several lipoxidized 
proteins 
 
Figure 5: Overrepresented pathways and connections of genes encoding neuroketal-
adducted proteins resulting from the analysis of enriched Gene Ontology (GO) terms using 
Cytoscape software, and including information from GO pathway and functions, KEEG, 
REACTOME and STRING databases. 
 
Figure 6: Slot-blot quantification of soluble oligomers (antibody A11) (A) and total 
neuroketal (NKT) (B) levels in the parietal cortex, frontal cortex and cingulate gyrus in 
middle-aged and old-aged individuals; significant differences between age groups are 
analyzed with the Student's t test. Correlation of oligomers with age is found in the parietal 
and frontal cortices; correlations of NKT and age in the frontal cortex (C).  
 
Figure 7: Significant positive correlations are found between soluble oligomers and 
neuroketal (NKT) levels in all regions (A). Relationships are summarized using principal 



























































































































































 Region-dependent brain protein lipoxidation occurs at middle age and increases in 
old age 
 Proteins involved in energy metabolism, cytoskeleton, proteostasis, 
neurotransmission and O2/CO2, and heme metabolism are the main targets 
 Sub-cellular localization, secondary structure and external exposition of certain 
amino acids are contributory factors in protein vulnerability 
 Non-identified oligomers correlate with protein neuroketal adduction    
 
 
 
 
